Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Colorectal Neoplasms

Free Subscription Articles published in Oncol Rep Retrieve available abstracts of 63 articles: HTML format

Single Articles

June 2024
1. XIONG Y, Wang J, Zhu H, Liu L, et al
   [Retracted] Chronic oxymatrine treatment induces resistance and epithelial?mesenchymal transition through targeting the long non?coding RNA MALAT1 in colorectal cancer cells.
   Oncol Rep. 2024;51:73.
   PubMed     Abstract available
   
   
   May 2024
2. ZHANG X, He L, Li Y, Qiu Y, et al
   Compound 225# inhibits the proliferation of human colorectal cancer cells by promoting cell cycle arrest and apoptosis induction.
   Oncol Rep. 2024;51:70.
   PubMed     Abstract available
   
   
   April 2024
3. SUSANTO AC, Hartajanie L, Wu CC
   alpha?Phellandrene enhances the apoptosis of HT?29 cells induced by 5?fluorouracil by modulating the mitochondria?dependent pathway.
   Oncol Rep. 2024;51:61.
   PubMed     Abstract available
   
   
   March 2024
4. LI XL, Zhou J, Xia CJ, Min H, et al
   [Corrigendum] PRIMA?1(met) induces autophagy in colorectal cancer cells through upregulation of the mTOR/AMPK?ULK1?Vps34 signaling cascade.
   Oncol Rep. 2024;51:44.
   PubMed     Abstract available
   
   
   February 2024
5. ZHANG M, Xiang F, Sun Y, Liu R, et al
   Ursolic acid inhibits the metastasis of colon cancer by downregulating ARL4C expression.
   Oncol Rep. 2024;51:27.
   PubMed     Abstract available
   
   
   
6. CHO SJ, Jeong BY, Yoon SH, Park CG, et al
   Rab25 suppresses colon cancer cell invasion through upregulating claudin?7 expression.
   Oncol Rep. 2024;51:26.
   PubMed     Abstract available
   
   
   
7. CAO R, Guo S, Min L, Li P, et al
   Roles of Rictor alterations in gastrointestinal tumors (Review).
   Oncol Rep. 2024;51:37.
   PubMed     Abstract available
   
   
   January 2024
8. CHI J, Liu S, Wu Z, Shi Y, et al
   [Retracted] circNSUN2 promotes the malignant biological behavior of colorectal cancer cells via the miR?181a?5p/ROCK2 axis.
   Oncol Rep. 2024;51:13.
   PubMed     Abstract available
   
   
   
9. LU M, Hu X, Cheng C, Zhang Y, et al
   RPF2 mediates the CARM1?MYCN axis to promote chemotherapy resistance in colorectal cancer cells.
   Oncol Rep. 2024;51:11.
   PubMed     Abstract available
   
   
   December 2023
10. ZHANG J, Li C, Sun L, Sun D, et al
    P53?microRNA interactions regulate the response of colorectal tumor cells to oxaliplatin under normoxic and hypoxic conditions.
    Oncol Rep. 2023;50:219.
    PubMed     Abstract available
    
    
    November 2023
11. DING M, Yan J, Chao G, Zhang S, et al
    Application of artificial intelligence in colorectal cancer screening by colonoscopy: Future prospects (Review).
    Oncol Rep. 2023;50:199.
    PubMed     Abstract available
    
    
    October 2023
12. SIM MK, Park JE, Kim SR, Lee J, et al
    Neuromedin U contributes to radiation resistance in colorectal cancer via YAP/TAZ signaling activation.
    Oncol Rep. 2023;50:178.
    PubMed     Abstract available
    
    
    
13. ALZAHRANI SM, Al Doghaither HA, Al-Ghafari AB, Pushparaj PN, et al
    5‑Fluorouracil and capecitabine therapies for the treatment of colorectal cancer (Review).
    Oncol Rep. 2023;50:175.
    PubMed     Abstract available
    
    
    
14. YAMAMOTO T, Shiburo R, Moriyama Y, Mitamura K, et al
    Protein components of maple syrup as a potential resource for the development of novel anti‑colorectal cancer drugs.
    Oncol Rep. 2023;50:179.
    PubMed     Abstract available
    
    
    
15. CHEN WS, Zhang X, Zhao ZF, Che XM, et al
    MBNL1?AS1 attenuates tumor cell proliferation by regulating the miR?29c?3p/BVES signal in colorectal cancer.
    Oncol Rep. 2023;50:191.
    PubMed     Abstract available
    
    
    September 2023
16. LIU Z, Fan L, Niu D, Chen M, et al
    Copper (II) complex of salicylate phenanthroline induces the apoptosis of colorectal cancer cells, including oxaliplatin‑resistant cells.
    Oncol Rep. 2023;50:170.
    PubMed     Abstract available
    
    
    July 2023
17. FENG WQ, Zhang YC, Gao H, Li WC, et al
    FOXD1 promotes chemotherapy resistance by enhancing cell stemness in colorectal cancer through beta‑catenin nuclear localization.
    Oncol Rep. 2023;50:134.
    PubMed     Abstract available
    
    
    
18. TANG B, Liang W, Liao Y, Li Z, et al
    [Retracted] PEA15 promotes liver metastasis of colorectal cancer by upregulating the ERK/MAPK signaling pathway.
    Oncol Rep. 2023;50:137.
    PubMed     Abstract available
    
    
    June 2023
19. MA F, Lin Y, Ni Z, Chen T, et al
    Therapeutic effects of natural polyphenols on colorectal adenomas: Focus on preclinical studies (Review).
    Oncol Rep. 2023;49:112.
    PubMed     Abstract available
    
    
    
20. ZHOU J, Chen S, Liu J, Du J, et al
    Knockdown of hnRNPAB reduces the stem cell properties and enhances the chemosensitivity of human colorectal cancer stem cells.
    Oncol Rep. 2023;49:129.
    PubMed     Abstract available
    
    
    
21. GONG JE, Kim JE, Park SH, Lee SJ, et al
    Anti‑tumor effects of an aqueous extract of Ecklonia cava in BALB/cKorl syngeneic mice using colon carcinoma CT26 cells.
    Oncol Rep. 2023;49:128.
    PubMed     Abstract available
    
    
    May 2023
22. WANG C, Xin H, Yan G, Liu Z, et al
    NONHSAG028908.3 sponges miR‑34a‑5p to promote growth of colorectal cancer via targeting ALDOA.
    Oncol Rep. 2023;49:89.
    PubMed     Abstract available
    
    
    
23. SUN LB, Zhao SF, Zhu JJ, Han Y, et al
    [Retracted] Long noncoding RNA UCID sponges miR‑152‑3p to promote colorectal cancer cell migration and invasion via the Wnt/beta‑catenin signaling pathway.
    Oncol Rep. 2023;49:92.
    PubMed     Abstract available
    
    
    
24. QIAN K, Zhang J, Lu J, Liu W, et al
    [Retracted] FAM172A modulates apoptosis and proliferation of colon cancer cells via STAT1 binding to its promoter.
    Oncol Rep. 2023;49:107.
    PubMed     Abstract available
    
    
    April 2023
25. KANG M, Su Z
    Increased expression of GIPC2 in colon adenocarcinoma is associated with a favorable prognosis and high levels of immune cell infiltration.
    Oncol Rep. 2023;49:66.
    PubMed     Abstract available
    
    
    
26. KIM HJ, Hong I, Roh S, Kim S, et al
    High expression of LY6E is an independent prognostic factor of colorectal cancer patients.
    Oncol Rep. 2023;49:80.
    PubMed     Abstract available
    
    
    March 2023
27. HARATA S, Suzuki T, Takahashi H, Hirokawa T, et al
    AZD6738 promotes the tumor suppressive effects of trifluridine in colorectal cancer cells.
    Oncol Rep. 2023;49:52.
    PubMed     Abstract available
    
    
    
28. XIE Y, Zhang Y, Liu X, Cao L, et al
    miR‑151a‑5p promotes the proliferation and metastasis of colorectal carcinoma cells by targeting AGMAT.
    Oncol Rep. 2023;49:50.
    PubMed     Abstract available
    
    
    
29. KIM JE, Lee SK, Park J, Jung MJ, et al
    Buddlejasaponin IV induces apoptotic cell death by activating the mitochondrial‑dependent apoptotic pathway and reducing alpha(2)beta(1) integrin‑mediated adhesion in HT‑29 human colorectal cancer cells.
    Oncol Rep. 2023;49:58.
    PubMed     Abstract available
    
    
    February 2023
30. LINDEMANN A, Brandes F, Borrmann M, Meidert AS, et al
    Anesthetic‑specific lncRNA and mRNA profile changes in blood during colorectal cancer resection: A prospective, matched‑case pilot study.
    Oncol Rep. 2023;49:28.
    PubMed     Abstract available
    
    
    
31. LOMBARDI P, Aimar G, Peraldo-Neia C, Bonzano A, et al
    Fluoropyrimidine‑induced cardiotoxicity in colorectal cancer patients: a prospective observational trial (CHECKPOINT).
    Oncol Rep. 2023;49:31.
    PubMed     Abstract available
    
    
    
32. JIANG T, Li H, Jiang R, Li H, et al
    [Retracted] Pin2/TRF1‑binding protein X1 inhibits colorectal cancer cell migration and invasion in vitro and metastasis in vivo via the nuclear factor‑kappaB signaling pathway.
    Oncol Rep. 2023;49:40.
    PubMed     Abstract available
    
    
    January 2023
33. TANG Y, Yi X, Zhang X, Liu B, et al
    Microcystin‑leucine arginine promotes colorectal cancer cell proliferation by activating the PI3K/Akt/Wnt/beta‑catenin pathway.
    Oncol Rep. 2023;49:18.
    PubMed     Abstract available
    
    
    
34. ROSTKOWSKA O, Olejniczak-Keder A, Spychalski P, Szarynska M, et al
    Triiodothyronine lowers the potential of colorectal cancer stem cells in vitro.
    Oncol Rep. 2023;49:21.
    PubMed     Abstract available
    
    
    November 2022
35. URH K, Zidar N, Tomazic A, Bostjancic E, et al
    Intratumor heterogeneity of cancer stem cellrelated genes and their potential regulatory microRNAs in metastasizing colorectal carcinoma.
    Oncol Rep. 2022;48.
    PubMed     Abstract available
    
    
    
36. LIU F, Su D, Zhang H, Lin HC, et al
    Clinical implications of the oralgut microbiome axis and its association with colorectal cancer (Review).
    Oncol Rep. 2022;48.
    PubMed     Abstract available
    
    
    
37. CIZAUSKAITE A, Simcikas D, Schultze D, Kallifatidis G, et al
    Sulforaphane has an additive anticancer effect to FOLFOX in highly metastatic human colon carcinoma cells.
    Oncol Rep. 2022;48.
    PubMed     Abstract available
    
    
    October 2022
38. LIU X, Wang Y, Zhao J
    [Retracted] MicroRNA337 inhibits colorectal cancer progression by directly targeting KRAS and suppressing the AKT and ERK pathways.
    Oncol Rep. 2022;48.
    PubMed     Abstract available
    
    
    
39. SI Y, Li L, Zhang W, Liu Q, et al
    GANT61 exerts anticancer cell and anticancer stem cell capacity in colorectal cancer by blocking the Wnt/betacatenin and Notch signalling pathways.
    Oncol Rep. 2022;48.
    PubMed     Abstract available
    
    
    June 2022
40. DAITOKU N, Miyamoto Y, Hiyoshi Y, Tokunaga R, et al
    Activin A promotes cell proliferation, invasion and migration and predicts poor prognosis in patients with colorectal cancer.
    Oncol Rep. 2022;47.
    PubMed     Abstract available
    
    
    
41. NAKAI N, Hara M, Takahashi H, Shiga K, et al
    Cancer cellinduced tissue inhibitor of metalloproteinase1 secretion by cancerassociated fibroblasts promotes cancer cell migration.
    Oncol Rep. 2022;47.
    PubMed     Abstract available
    
    
    May 2022
42. SATO N, Sakai N, Furukawa K, Takayashiki T, et al
    Yin Yang 1 regulates ITGAV and ITGB1, contributing to improved prognosis of colorectal cancer.
    Oncol Rep. 2022;47.
    PubMed     Abstract available
    
    
    
43. ZHAO P, Zhou P, Tang T, Si R, et al
    Levels of circulating mast cell progenitors and tumourinfiltrating mast cells in patients with colorectal cancer.
    Oncol Rep. 2022;47.
    PubMed     Abstract available
    
    
    
44. LEE MH, Hong SH, Park C, Kim GY, et al
    [Corrigendum] Hwang-Heuk-San induces apoptosis in HCT116 human colorectal cancer cells through the ROS-mediated activation of caspases and the inactivation of the PI3K/Akt signaling pathway.
    Oncol Rep. 2022;47.
    PubMed     Abstract available
    
    
    
45. XU Y, Liu X, Zhang H, Zhu Z, et al
    [Corrigendum] Overexpression of HES6 has prognostic value and promotes metastasis via the Wnt/beta-catenin signaling pathway in colorectal cancer.
    Oncol Rep. 2022;47.
    PubMed     Abstract available
    
    
    
46. YOSHIMOTO T, Shimada M, Tokunaga T, Nakao T, et al
    Blue light irradiation inhibits the growth of colon cancer and activation of cancerassociated fibroblasts.
    Oncol Rep. 2022;47.
    PubMed     Abstract available
    
    
    April 2022
47. LI J, Xu J, Yan X, Jin K, et al
    [Retracted] MicroRNA485 plays tumoursuppressive roles in colorectal cancer by directly targeting GAB2.
    Oncol Rep. 2022;47.
    PubMed     Abstract available
    
    
    
48. HAN J, Liu Z, Wang N, Pan W, et al
    [Retracted] MicroRNA874 inhibits growth, induces apoptosis and reverses chemoresistance in colorectal cancer by targeting Xlinked inhibitor of apoptosis protein.
    Oncol Rep. 2022;47.
    PubMed     Abstract available
    
    
    
49. ZHAO J, Xu J, Zhang R
    [Retracted] MicroRNA-411 inhibits malignant biological behaviours of colorectal cancer cells by directly targeting PIK3R3.
    Oncol Rep. 2022;47.
    PubMed     Abstract available
    
    
    
50. SUZUKI T, Hirokawa T, Maeda A, Harata S, et al
    ATR inhibitor AZD6738 increases the sensitivity of colorectal cancer cells to 5fluorouracil by inhibiting repair of DNA damage.
    Oncol Rep. 2022;47.
    PubMed     Abstract available
    
    
    March 2022
51. YAN Z, Zhou Y, Yang Y, Zeng C, et al
    Zinc finger protein 384 enhances colorectal cancer metastasis by upregulating MMP2.
    Oncol Rep. 2022;47.
    PubMed     Abstract available
    
    
    February 2022
52. ZHANG S, Yu M, Chen D, Li P, et al
    Role of MRIbased radiomics in locally advanced rectal cancer (Review).
    Oncol Rep. 2022;47.
    PubMed     Abstract available
    
    
    January 2022
53. ZEYA B, Nafees S, Imtiyaz K, Uroog L, et al
    Diosmin in combination with naringenin enhances apoptosis in colon cancer cells.
    Oncol Rep. 2022;47.
    PubMed     Abstract available
    
    
    
54. CHEN W, Dai G, Qian Y, Wen L, et al
    PIK3CA mutation affects the proliferation of colorectal cancer cells through the PI3K-MEK/PDK1-GPT2 pathway.
    Oncol Rep. 2022;47.
    PubMed     Abstract available
    
    
    
55. TAK E, Kim M, Cho Y, Choi S, et al
    Expression of neurofibromin 1 in colorectal cancer and cetuximab resistance.
    Oncol Rep. 2022;47.
    PubMed     Abstract available
    
    
    December 2021
56. XIE Y, Wang F, Yu J, Zhang J, et al
    Silencing of MBD2 and EZH2 inhibits the proliferation of colorectal carcinoma cells by rescuing the expression of SFRP.
    Oncol Rep. 2021;46.
    PubMed     Abstract available
    
    
    November 2021
57. LI Y, Qian X, Lin Y, Tao L, et al
    Lipidomic profiling reveals lipid regulation by a novel LSD1 inhibitor treatment.
    Oncol Rep. 2021;46.
    PubMed     Abstract available
    
    
    August 2021
58. ASANO T, Ohishi T, Takei J, Nakamura T, et al
    AntiHER3 monoclonal antibody exerts antitumor activity in a mouse model of colorectal adenocarcinoma.
    Oncol Rep. 2021;46.
    PubMed     Abstract available
    
    
    June 2021
59. ZHANG YL, Wen XD, Guo X, Huang SQ, et al
    Progesterone suppresses the progression of colonic carcinoma by increasing the activity of the GADD45alpha/JNK/cJun signalling pathway.
    Oncol Rep. 2021;45.
    PubMed     Abstract available
    
    
    May 2021
60. FREUND E, Miebach L, Stope MB, Bekeschus S, et al
    Hypochlorous acid selectively promotes toxicity and the expression of danger signals in human abdominal cancer cells.
    Oncol Rep. 2021;45.
    PubMed     Abstract available
    
    
    March 2021
61. SZCZYGIEL A, Anger-Gora N, Wegierek-Ciura K, Mierzejewska J, et al
    Immunomodulatory potential of anticancer therapy composed of methotrexate nanoconjugate and dendritic cellbased vaccines in murine colon carcinoma.
    Oncol Rep. 2021;45:945-962.
    PubMed     Abstract available
    
    
    
62. VERDINA A, Di Segni M, Amoreo CA, Sperduti I, et al
    HIPK2 is a potential predictive marker of a favorable response for adjuvant chemotherapy in stage II colorectal cancer.
    Oncol Rep. 2021;45:899-910.
    PubMed     Abstract available
    
    
    
63. WANG X, Song Z, Hu B, Chen Z, et al
    MicroRNA‑642a‑5p inhibits colon cancer cell migration and invasion by targeting collagen type I alpha1.
    Oncol Rep. 2021;45:933-944.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.